Searchable abstracts of presentations at key conferences in endocrinology

ea0028p372 | Thyroid | SFEBES2012

Langerhans cell histiocytosis and Graves’ disease

Abbara Ali , Chhina Navpreet , Joharatnam Jalini , Tharakan George , Todd Jeannie

A 27 year old lady with a background of Langerhans cell histiocytosis (LCH) presented to endocrinology clinic for investigation of thyrotoxicosis. At the age of three years old, she presented with a rash on her forehead, which on biopsy revealed Langerhans cell histiocytosis. She was also noted to have symptoms consistent with diabetes insipidus, for which she remains on desmopressin therapy. At the age of six she received pituitary radiotherapy and 6 years ago developed secon...

ea0025p56 | Clinical biochemistry | SFEBES2011

Hormone profile of patients referred for Bariatric surgery

Varadhan Lakshminarayanan , Cheruvu C V N , Varughese George , Clayton Richard

Aim: An increasing proportion of patients are referred to endocrine clinics for assessment of an endocrine reason for obesity. The aim of our study was to assess the hormone profiles of patients referred for bariatric surgery.Methods: Patients referred to bariatric surgery clinic were investigated for hypothyroidism (TSH, T4), Cushing’s disease (2 mg-overnight dexamethasone suppression test), acromegaly (IGF1) and Vitamin D deficiency (PT...

ea0023p25 | (1) | BSPED2009

Diagnostic Challenges in Androgen Insensitivity Syndrome & 5 Alpha Reductase Deficiency

George E T , Alvi S , Taylor N K , Mushtaq T

Introduction: The clinical differentiation between androgen insensitivity syndrome (AIS) and 5 alpha reductase deficiency (5-ARD) can be difficult. Presenting features may be similar and initial investigations may still not be discriminatory.Methods: Case notes on a total of ten patients with the initial diagnosis of AIS or 5-ARD were retrospectively reviewed.Results: All ten children had a 46XY male karyotype. Four children were r...

ea0022p415 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Atypical bronchopulmonary carcinoid tumor metastatic to endocrine glands and bone marrow

Daraki Vasiliki , Stamou Konstantina , Mamalaki Evangelia , Kalikakis George , Papavasiliou Stathis

Bronchopulmonary neuroendocrine tumors (BP-NETs) comprise 20% of all lung cancers. Typical low grade carcinoid tumors (TC) represent the majority of BP-carcinoids. Intermediate grade atypical carcinoid tumors (AC) are less often encountered but more aggressive. Although metastatic dissemination to mediastinal lymph nodes as well as liver, skeleton, central nervous system, skin and mammary glands is well known, the involvement of endocrine glands is really rare.<p class="ab...

ea0021oc2.6 | Neuroendocrine tumours/pituitary | SFEBES2009

Laying the foundation for neuroendocrine control of human reproduction: an investigation into the development of kisspeptin and neurokinin B networks

Tello Javier , George Jyothis , Millar Mike , Anderson Richard , Millar Robert

The development and maturation of kisspeptin neurons is critical for activating GnRH release needed to initiate puberty. However, little is known of the development and organization of kisspeptin neurons in the human hypothalamus and the anatomical architecture of kisspeptin neurons in rodents is distinct from that of primates.The aim of the present study was to examine the development of the hypothalamic neuroendocrine circuitry that sets the structural...

ea0021p43 | Clinical practice/governance and case reports | SFEBES2009

Testosterone replacement in the setting of Finasteride therapy: a therapeutic dilemma

Hariman Christian , Varadhan Laks , Walker Adrian , Varughese George

Introduction: Benign prostatic hypertrophy is common amongst elderly men, and usually treated with the testosterone blocker, finasteride. However, the treatment of such a condition alongside hypo-pituitarism and low testosterone levels presents with a therapeutic dilemma.Case report: An 88-year-old gentleman who was admitted following recurrent episodes of confusion and falls was found to have a serum sodium level of 114 mmol/l, serum osmolality of 258 m...

ea0021p44 | Clinical practice/governance and case reports | SFEBES2009

Addison's disease unmasking an occult systemic cause for cerebral ischaemic event

Hariman Christian , Varadhan Laks , Natarajan Indira , Walker Adrian , Varughese George

Introduction: Cerebral ischaemic events in young patients due to patent foramen ovale are rare. A more plausible diagnosis had clouded the initial management and diagnosis of such a case in a young male patient.Case report: A 19-year-old gentleman was admitted with vomiting and profound hyponatraemia of 99 mmol/l. He was diagnosed to have Addison’s disease (with positive adrenal antibodies) following a flat short synacthen test. He warranted ITU adm...

ea0021p67 | Clinical practice/governance and case reports | SFEBES2009

Hypercalcaemia due to PTH-related peptide secretion by small cell carcinoma of the ovary

Simpson Katherine , Tharakan George , Coady Andy , Padwick Malcolm , Clements Michael

A 45-year-old woman presented with a 6-week history of constipation and generalised abdominal pains. Blood biochemistry revealed a corrected serum calcium of 4.99 mmol/l, phosphate 0.82 mmol/l, and intact parathyroid hormone (i-PTH) of 0.2 pmol/l (normal range 1–6.1 pmol/l). Serum parathyroid hormone related peptide (PTH-rP) was 5.3 pmol/l (normal range <1.8 pmol/l). Computed tomography demonstrated an 11.0×11.6 cm ovarian tumour with cystic and solid areas and h...

ea0020p432 | Diabetes and Cardiovascular | ECE2009

Can testosterone therapy be included into diabetes treatment in men with metabolic syndrome and hypogonadism?

Kalinchenko Svetlana , Saad Farid , Mskhalaya George , Tishova Yuliya

Background: In 1998 the UKPDS study showed that over 10 years of observation there were no significant changes in haemoglobin A1c (HbA1c) in intensive insulin therapy group compared with conventional therapy group. Therefore, we still need new options to treat diabetes. Diabetes mellitus type 2 (DMT2), is one of the MS components. Obesity leads to insulin resistance (IR) and DMT2. Androgen deficiency (AD) is well-known factor to predict the development of diabetes.<p class...

ea0020p502 | Obesity and Metabolism | ECE2009

Prevalence of the metabolic syndrome in men with late-diagnosed Klinefelter syndrome

Gusakova Daria , Kalinchenko Svetlana , Mskhalaya George , Tishova Yuliya

Introduction: Klinefelter syndrome (KS) is the most common sex-chromosome disorder with a prevalence of 1 in every 660 men, but only 25% of the expected number of patients are diagnosed. It is also one of the most common endocrine disorders, and takes the third place after diabetes mellitus and thyroid gland diseases. KS is one of the most frequent causes of hypogonadism in men. It is known that hypogonadism in men has been found to be an independent risk factor for developmen...